Please do not leave this page until complete. This can take a few moments.
The losses rose in the third quarter for Holliston biotech startup Biostage as the company continues to push towards clinical trials of its esophageal implants.
On Tuesday, Biostage reported a net loss of $2.4 million, or a net loss per share of $0.33, compared to a net loss of $2.1 million, or a net loss per share of $0.37 for the third quarter of 2018. This continued a downward trend for the company, with year-to-date net losses of $6.7 million, or a net loss per share of $1.02, compared to a net loss of $5.7 million, or a net loss per share of $1.40, at this point last year.
The continued losses were attributed to a $1.2-million increase in research and development costs and a $200,000 increase in general and administrative expenses. These were partially offset by a $200,000 net decrease in expense.
On Oct. 29, Biostage submitted its investigational new drug application to the U.S. Food and Drug Administration for the company’s lead product candidate, the Cellspan Esophageal Implant. According to Biostage CEO James McGorry, this marks the Biostage’s transition to a clinical stage company.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments